DATASHEET
Host:
Rabbit
Target Protein:
DRD4
Immunogen Range:
151-250/467
Clonality:
Polyclonal
Isotype:
IgG
Entrez Gene:
1815
Swiss Prot:
P21917
Source:
KLH conjugated synthetic peptide derived from human DRD4
Purification:
Purified by Protein A.
Storage Buffer:
0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Storage:
Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
Background:
This gene encodes the D4 subtype of the dopamine receptor. The D4 subtype is a G-protein coupled receptor which inhibits adenylyl cyclase. It is a target for drugs which treat schizophrenia and Parkinson disease. Mutations in this gene have been associated with various behavioral phenotypes, including autonomic nervous system dysfunction, attention deficit/hyperactivity disorder, and the personality trait of novelty seeking. This gene contains a polymorphic number (2-10 copies) of tandem 48 nt repeats; the sequence shown contains four repeats.DRD4 expression has been reported in various regions of the brain as well as in adrenal gland, artery, eye, heart, kidney, placenta, spinal cord, testis, and vas deferens.
PRODUCT SPECIFIC PUBLICATIONS
- ai L et al. m6A demethylase FTO regulates dopaminergic neurotransmission deficits caused by arsenite.Toxicol Sci. 2018 Oct 1;165(2):431-446.Read more>>
VALIDATION IMAGES
Hela cell lysates probed with Dopamine D4 receptor Polyclonal Antibody, Unconjugated (bs-1746R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Mouse Cerebrum lysates probed with DRD4 Polyclonal Antibody, Unconjugated (bs-1746R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.
Lane 1: Hela cell lysates;Lane 2: Mouse urinary bladder lysates;Lane 3: Mouse Cerebrum lysates; Lane 4:Mouse Liver lysates probed with DRD4 Polyclonal Antibody, Unconjugated (bs-1746R) at 1:1000 dilution and 4˚C overnight incubation. Followed by conjugated secondary antibody incubation at 1:20000 for 60 min at 37˚C.